FAPI-46
Showing 1 - 25 of 519
Cancer, Peritoneal Carcinomatosis Trial in Brussels (FAPI PET/CT)
Recruiting
- Cancer
- Peritoneal Carcinomatosis
- FAPI PET/CT
-
Brussels, BelgiumInstitut Jules Bordet
Sep 25, 2023
Pancreatic Cancer, Cholangiocarcinoma Trial in Amsterdam ([68Ga]Ga-FAPI-46 PET/CT)
Recruiting
- Pancreatic Cancer
- Cholangiocarcinoma
- [68Ga]Ga-FAPI-46 PET/CT
-
Amsterdam, Noord-Holland, NetherlandsAmsterdam UMC, location VUmc
Jul 13, 2023
Lobular Breast Carcinoma Trial in Monaco (68Ga-FAPI-46 PET scan)
Not yet recruiting
- Lobular Breast Carcinoma
- 68Ga-FAPI-46 PET scan
-
Monaco, MonacoCentre Hospitalier Princesse Grace
Jun 27, 2023
Lung Cancer Trial in Taoyuan (68Ga-FAPI-46)
Not yet recruiting
- Lung Cancer
- 68Ga-FAPI-46
-
Taoyuan, TaiwanDepartment of Nuclear Medicine, Chang Gung Memorial Hospital
Nov 16, 2022
Metastatic Malignant Tumor in the Prostate Gland, Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in Los Angeles
Recruiting
- Metastatic Malignant Neoplasm in the Prostate Gland
- +2 more
- Computed Tomography
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Jul 18, 2022
Metastatic Sarcoma, Recurrent Sarcoma, Sarcoma Trial in Los Angeles (Computed Tomography, Gallium Ga 68 FAPi-46, Positron
Recruiting
- Metastatic Sarcoma
- +2 more
- Computed Tomography
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Apr 1, 2022
PDAC - Pancreatic Ductal Adenocarcinoma, FAP Trial in New York ([68Ga]FAPI-46)
Recruiting
- PDAC - Pancreatic Ductal Adenocarcinoma
- FAP
-
New York, New YorkNYU Langone Health
May 3, 2022
Hepatocellular Carcinoma Trial (Radiolabelled tracer, 68Gallium-FAPI-46 PET/MRI)
Not yet recruiting
- Hepatocellular Carcinoma
- Radiolabelled tracer, 68Gallium-FAPI-46 PET/MRI
- (no location specified)
Jan 8, 2023
Interstitial Lung Disease, Idiopathic Interstitial Pneumonias, Drug-Induced Pneumonitis Trial in Los Angeles (68Ga-FAPi-46,
Recruiting
- Interstitial Lung Disease
- +6 more
- 68Ga-FAPi-46
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
May 6, 2022
Tumor, Solid Trial in Essen (68Ga-FAPI-46 PET Scan)
Recruiting
- Tumor, Solid
- 68Ga-FAPI-46 PET Scan
-
Essen, NRW, GermanyDepartment of Nuclear medicine, University hospital Essen
Dec 15, 2021
Solid Tumor, Unspecified, Adult Trial in Meldola (68 Gallium -Fibroblast Activating Protein Inhibitor -46 Positron emission
Recruiting
- Solid Tumor, Unspecified, Adult
- 68 Gallium -Fibroblast Activating Protein Inhibitor -46 Positron emission tomography / Computerized tomography
-
Meldola, Forlì Cesena, ItalyIRCCS Istituto ROmagnolo per lo Studio dei Tumori "Dino Amadori"
Nov 15, 2023
Breast Carcinoma, Colon Carcinoma, Esophageal Carcinoma Trial in Los Angeles (Computed Tomography, Gallium Ga 68 FAPi-46,
Recruiting
- Breast Carcinoma
- +10 more
- Computed Tomography
- +4 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Nov 29, 2022
Breast Tumors, Positron Emission Tomography, Fibroblast Activation Protein Inhibitor Trial in Baku (68Ga-FAPI-46 PET/CT)
Recruiting
- Breast Neoplasms
- +3 more
- 68Ga-FAPI-46 PET/CT
-
Baku, AzerbaijanNational Centre of Oncology
Jun 21, 2022
Tumor, Solid, FAPI, PET/CT, Metastasis Trial in Xiamen (68Ga-DOTA-FAPI-46 and 68Ga-DOTA-2P(FAPI)2 PET/CT)
Recruiting
- Tumor, Solid, FAPI, PET/CT, Metastasis
- 68Ga-DOTA-FAPI-46 and 68Ga-DOTA-2P(FAPI)2 PET/CT
-
Xiamen, Fujian, ChinaThe First affiliated hospital of xiamen university
Jun 25, 2021
Cancer of Unknown Primary Site Trial in Bendigo, Melbourne, Warrnambool (68Ga-FAPi-46, PET/CT imaging)
Not yet recruiting
- Cancer of Unknown Primary Site
- 68Ga-FAPi-46
- PET/CT imaging
-
Bendigo, Victoria, Australia
- +2 more
Feb 28, 2022
Pancreatic Tumors, Stomach Tumors, Bile Duct Tumors Trial in Stockholm (68Ga-FAPI-46, PET/CT)
Recruiting
- Pancreatic Neoplasms
- +3 more
- 68Ga-FAPI-46
- PET/CT
-
Stockholm, SwedenKarolinska University Hospital Huddinge
Dec 13, 2021
Non Small Cell Lung Cancer Trial in Brussels (FAPI PET/CT)
Recruiting
- Non Small Cell Lung Cancer
- FAPI PET/CT
-
Brussels, BelgiumInstitut Jules Bordet
Oct 24, 2023
SSTR2, FAP, Positron-Emission Tomography Trial in Xiamen (18F-FDG PET/CT, 68Ga-FAPI-LM3 PET/CT)
Recruiting
- SSTR2
- +2 more
- 18F-FDG PET/CT, 68Ga-FAPI-LM3 PET/CT
-
Xiamen, Fujian, ChinaThe First Affiliated Hospital of Xiamen University
May 24, 2023
Refractory Thyroid Gland Carcinoma, Refractory Thyroid Gland Papillary Carcinoma, Refractory Thyroid Gland Follicular Carcinoma
Recruiting
- Refractory Thyroid Gland Carcinoma
- +3 more
- 177Lu-DOTA-EB-FAPI 1 radionuclide therapy
- +2 more
-
Xiamen, ChinaThe First Affiliated Hospital of Xiamen University
Nov 3, 2022
Refractory Solid Tumor Trial in Xiamen (177Lu-DOTA-EB-FAPI radionuclide therapy)
Recruiting
- Refractory Solid Tumor
- 177Lu-DOTA-EB-FAPI radionuclide therapy
-
Xiamen, Fujian, ChinaThe First Affiliated Hospital of Xiamen University
Jul 26, 2023
Tumor, Solid, Positron-Emission Tomography Trial in Xiamen (18F-FDG PET/CT, 68Ga-FAPI-RGD PET/CT)
Recruiting
- Tumor, Solid
- Positron-Emission Tomography
- 18F-FDG PET/CT, 68Ga-FAPI-RGD PET/CT
-
Xiamen, Fujian, ChinaThe First Affiliated Hospital of Xiamen University
Sep 16, 2022
Tumor, Solid Trial in Beijing (68Ga-DOTA-F2 PET/CT and 18F-FDG)
Recruiting
- Tumor, Solid
- 68Ga-DOTA-F2 PET/CT and 18F-FDG
-
Beijing, Beijing, ChinaPeking union medical college hospital
Nov 27, 2022
Tumor, Solid, Positron-Emission Tomography Trial in Xiamen (18F-FDG)
Recruiting
- Tumor, Solid
- Positron-Emission Tomography
- 18F-FDG
-
Xiamen, Fujian, ChinaThe First affiliated hospital of xiamen university
Aug 8, 2022